Company intelligence / Profile preview

Emfret Analytics

Eibelstadt, Bavaria, Germanybayern-international.de ↗

Ownership: Private
Development stage: Commercial

Overview

Emfret Analytics is a leading provider of specialized research tools, including monoclonal antibodies such as JAQ1 for vascular biology and glycoprotein VI analysis. Their products are widely used in cell/molecular biology, immunology, neuroscience, and vascular research by academic and industrial scientists globally[1][5]. The company focuses on delivering high-quality reagents that support robust scientific investigations[1].

Modalities: Monoclonal antibodyAntibody (general)Reagent (for research use)
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Emfret Analytics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emfret Analytics.

Explore the full profile